Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GANX
GOSS
Add up to 3 more stocks
GANX
Gain Therapeutics, Inc.
+1.15%
$1.71+0.02Delayed quote: Oct 6, 2026, 10:45 AM EDT
Market Cap
$72.92M
52W Range
$1.53 - $4.34
GOSS
Gossamer Bio, Inc.
-0.38%
$10.61-0.04Delayed quote: Oct 6, 2026, 10:45 AM EDT
Market Cap
$64.83M
52W Range
$9.10 - $309.60
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 6.46 | N/A |
| P/S Ratio | N/A | 1.22 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 99.6% |
| Operating Margin | 0.0% | -336.8% |
| Net Margin | 0.0% | -235.0% |
| ROE | -178.1% | N/A |
| ROA | -130.4% | -162.9% |
| ROIC | -159.2% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.36 | 0.53 |
| Quick Ratio | 4.36 | 0.53 |
| Debt/Equity | 0.05 | N/A |
| Interest Coverage | N/A | -14.86 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.